Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.


Updates from The Motley Fool

Latest updates on Bristol-Myers Squibb from Fool.com.  The Fool has written over 900 articles on Bristol-Myers Squibb.


Stock Performance

View Interactive BMY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Bristol-Myers Squibb.
Current Price: $61.01
Prev Close: $61.11
Open: $61.30
Bid: $61.05
Ask: $61.06
Day's Range: $60.80 - $61.59
52wk Range: $49.96 - $70.05
Volume: 2,866,566
Avg Vol 5,747,123
Market Cap: $100B
P/E (ttm): 254.62
EPS (ttm): $0.24
Div & Yield: $1.60 (2.6%)

Company Rating

What our community thinks about Bristol-Myers Squibb.
CAPS Rating 4 out of 5
 
1743 Outperform
117 Underperform
CAPS All Stars
 
385 Outperform
18 Underperform

How do you think Bristol-Myers Squibb will perform against the market?



You pick for Bristol-Myers Squibb is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Giovanni Caforio, CEO

81% Approve

Based on 398 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Bristol-Myers Squibb.

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers